CLINICAL_TRIALS
trial_result
· 2019-09-16
Clinical Trial Update: A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes [Phase 4]
Summary
A Phase 4 clinical trial update evaluating dulaglutide in Japanese participants with type 2 diabetes has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2019-09-16